These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6262162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ, Fanget B, Nicolas AJ.
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [Abstract] [Full Text] [Related]

  • 3. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL, van der Velden-de Groot CA, van Herwaarden JA.
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
    Montagnon BJ, Nicolas AJ, Fanget B, Peyron L.
    Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
    [Abstract] [Full Text] [Related]

  • 7. Cell substrate for killed poliovaccine production.
    Beale AJ.
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Developments in the production and quality control of poliovirus vaccines -- historical perspectives.
    Furesz J.
    Biologicals; 2006 Jun; 34(2):87-90. PubMed ID: 16621594
    [Abstract] [Full Text] [Related]

  • 12. Inactivated poliovirus vaccine: current production methods and new developments.
    van Wezel AL, van Steenis G, van der Marel P, Osterhaus AD.
    Rev Infect Dis; 1984 Jun; 6 Suppl 2():S335-40. PubMed ID: 6429814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serially subcultivated cells as substrates for poliovirus production for vaccine.
    von Seefried A, Chun JH.
    Dev Biol Stand; 1981 Jun; 47():25-33. PubMed ID: 6262151
    [Abstract] [Full Text] [Related]

  • 17. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells.
    Mann GF, de Mucha J.
    Dev Biol Stand; 1981 Jun; 37():255-8. PubMed ID: 201522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.
    Salk J, Stoeckel P, van Wezel AL, Lapinleimu K, van Steenis G.
    Ann Clin Res; 1982 Dec; 14(5-6):204-12. PubMed ID: 7171229
    [Abstract] [Full Text] [Related]

  • 20. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.
    Montagnon B, Vincent-Falquet JC, Fanget B.
    Dev Biol Stand; 1983 Dec; 55():37-42. PubMed ID: 6677539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.